Skip to Main Content

Author Details

Dennis Wang
Sheffield Institute of Translational Neuroscience, University of Sheffield
2006
20
17
PMIDPaper TitleJournal TitlePublished Year
30978569Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non-Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion.Neoplasia2019
31330989Somatic Alteration Burden Involving Non-Cancer Genes Predicts Prognosis in Early-Stage Non-Small Cell Lung Cancer.Cancers (Basel)2019
31209238Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen.Nat Commun2019
27750381Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.Int J Cancer2017
27923825Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery.Cancer Immunol Res2017
27965317Cell-Specific Computational Modeling of the PIM Pathway in Acute Myeloid Leukemia.Cancer Res2017
26148229Integrin α11β1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer.Oncogene2016
27880766SOX2 and PI3K Cooperate to Induce and Stabilize a Squamous-Committed Stem Cell Injury State during Lung Squamous Cell Carcinoma Pathogenesis.PLoS Biol2016
27550940Identification of Pharmacodynamic Transcript Biomarkers in Response to FGFR Inhibition by AZD4547.Mol Cancer Ther2016
27153664Combenefit: an interactive platform for the analysis and visualization of drug combinations.Bioinformatics2016
26926157Cetuximab Inhibits T790M-Mediated Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in a Lung Adenocarcinoma Patient-Derived Xenograft Mouse Model.Clin Lung Cancer2016
26124487Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma.J Clin Oncol2015
25551685Cell surface marker profiling of human tracheal basal cells reveals distinct subpopulations, identifies MST1/MSP as a mitogenic signal, and identifies new biomarkers for lung squamous cell carcinomas.Respir Res2014
25429762Integrated omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact.Nat Commun2014
23275551Transcription factor and chromatin features predict genes associated with eQTLs.Nucleic Acids Res2013
24386371Loss of canonical Smad4 signaling promotes KRAS driven malignant transformation of human pancreatic duct epithelial cells and metastasis.PLoS One2013
22721266Transcription factor co-localization patterns affect human cell type-specific gene expression.BMC Genomics2012
20028552Computational modeling of the EGFR network elucidates control mechanisms regulating signal dynamics.BMC Syst Biol2009
18238804Interoperability with Moby 1.0--it's better than sharing your toothbrush!Brief Bioinform2008
17030794The complete genome of Rhodococcus sp. RHA1 provides insights into a catabolic powerhouse.Proc Natl Acad Sci U S A2006
  • 1 - 20 of 20

Recommended Authors

Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 4
Broad Institute of Harvard and MIT
Career Start Year 2010
Number of shared co-authors 0
Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 0
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 7
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 4
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 1
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 8
Baylor College of Medicine
Career Start Year 2005
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 5
Rogel Cancer Center, University of Michigan ann arbor
Career Start Year 2005
Number of shared co-authors 0
Icahn School of Medicine
Career Start Year 2004
Number of shared co-authors 10
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 20
Broad Institute of Harvard and MIT
Career Start Year 2004
Number of shared co-authors 6
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 5
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 4
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 0
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 1
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 6
Genentech Inc.
Career Start Year 2002
Number of shared co-authors 0
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 2
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 0
Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center
Career Start Year 2000
Number of shared co-authors 4
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 7
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 4
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 6
Columbia University
Career Start Year 1993
Number of shared co-authors 8
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 0
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 7
University of California San Diego
Career Start Year 1988
Number of shared co-authors 3
Broad Institute
Career Start Year 1983
Number of shared co-authors 14

Collaborators

University Health Network, University of Toronto
Co-authored papers 10
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 7
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 7
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 6
University Health Network, Princess Margaret Cancer Centre
Co-authored papers 5
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Co-authored papers 5
The Princess Margaret Cancer Centre/University of Toronto
Co-authored papers 5
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Present Address: Tempus Labs Inc.
Co-authored papers 3
Hospital for Sick Children, University of Toronto
Co-authored papers 3
Hospital for Sick Children
Co-authored papers 3
Yamagata Prefectural Central Hospital
Co-authored papers 3
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Schroeder Arthritis Institute
Co-authored papers 3
Toronto General Hospital
Co-authored papers 3
Inha University Hospital
Co-authored papers 3
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
UCL Cancer Institute, University College London
Co-authored papers 2
Harvard Medical School
Co-authored papers 2
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Genomics England Ltd
Co-authored papers 2
Margaret Cancer Center
Co-authored papers 2
Henry Ford Hospital
Co-authored papers 2
University Health Network, University Health Network and University of Toronto
Co-authored papers 2
Hospital for Sick Children
Co-authored papers 2